COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 155 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $484,610 | -16.6% | 15,050 | +0.6% | 0.04% | +30.3% |
| Q1 2024 | $580,747 | +26.1% | 14,960 | 0.0% | 0.03% | +22.2% |
| Q4 2023 | $460,469 | +91.1% | 14,960 | +26.6% | 0.03% | +107.7% |
| Q1 2022 | $241,000 | -36.4% | 11,815 | -41.8% | 0.01% | -23.5% |
| Q4 2021 | $379,000 | -7.8% | 20,302 | -2.5% | 0.02% | -19.0% |
| Q3 2021 | $411,000 | – | 20,826 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $2,364,000 | 4.71% |
| GREAT POINT PARTNERS LLC | 861,410 | $20,364,000 | 4.27% |
| Rubric Capital Management LP | 2,420,214 | $57,214,000 | 3.60% |
| Camber Capital Management LP | 2,000,000 | $47,280,000 | 1.59% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 416,244 | $9,840,000 | 1.10% |
| Eventide Asset Management | 2,629,593 | $62,164,000 | 0.84% |
| RICE HALL JAMES & ASSOCIATES, LLC | 799,298 | $18,895,000 | 0.67% |
| EMERALD ADVISERS, LLC | 741,278 | $17,524,000 | 0.64% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 790,391 | $18,685,000 | 0.61% |
| Values First Advisors, Inc. | 37,222 | $880,000 | 0.60% |